Literature DB >> 2502020

Tissue plasminogen activator and the corneal endothelium.

M L McDermott1, H F Edelhauser, R A Hyndiuk, S B Koenig.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2502020     DOI： 10.1016/s0002-9394(14)73273-8

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  4 in total

1.  The use of tissue plasminogen activator in post-traumatic total hyphaema.

Authors:  L Laatikainen; J Mattila
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-01       Impact factor: 3.117

2.  Recombinant tissue plasminogen activator following paediatric cataract surgery.

Authors:  J S Mehta; G G Adams
Journal:  Br J Ophthalmol       Date:  2000-09       Impact factor: 4.638

3.  Intracameral tissue plasminogen activator to prevent severe fibrinous effusion after congenital cataract surgery.

Authors:  H Siatiri; A H Beheshtnezhad; H Asghari; N Siatiri; S Moghimi; N Piri
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

4.  Recombinant tissue plasminogen activator in cases with fibrin formation after cataract surgery: a prospective randomised multicentre study.

Authors:  A Heiligenhaus; B Steinmetz; R Lapuente; P Krallmann; C Althaus; W K Steinkamp; B Dick
Journal:  Br J Ophthalmol       Date:  1998-07       Impact factor: 4.638
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.